The Efficacy of Anti-VEGF Therapy for Putative or Visible CNV in Central Serous Chorioretinopathy by Optical Coherence Tomography Angiography
Table 1
Baseline characteristics of all eyes included in the study.
Criteria
All eyes
Visible CNV group
Putative CNV group
-value
Patients (n)
16
6
10
—
Age (mean ± SD)
51.1 ± 8.0
51.9 ± 8.1
50.6 ± 7.9
0.762
Gender (male/Female)
9/6
3/3
6/4
0.696
Mean interval of follow-up (months) (mean ± SD)
3.90 ± 3.37
4.29 ± 3.42
3.67 ± 3.32
0.743
Affected eye (right/Left)
7/9
3/3
4/6
0.696
The number of injections (mean ± SD)
2.69 ± 1.72
2.67 ± 2.13
2.70 ± 1.42
0.973
Mean interval between injections in months (mean ± SD)
1.34 ± 0.87
1.42 ± 0.99
1.29 ± 0.78
0.716
Type of fluid accumulation (Subretinal/PED)
16/16
6/6
10/10
—
CNV, choroidal neovascularization; PED, pigment epithelial detachment. The data were represented as mean ± SD; one patient with both eyes affected. The statistics was analyzed by the chi-square test or independent t-test when appropriated.
